Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational Drug Exposure Registry for Long-Term Follow-Up of Subjects Exposed to GSK2248761
2011-003303-38Phase 2Completed
- Sponsor
- ViiV Healthcare
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Fosdevirine in Human immunodeficiency virus infection type 1, sponsored by ViiV Healthcare. Primary endpoint: Quarterly safety and HIV disease status data collection. Started Aug 2011; status: completed.
02
Drugs
Fosdevirine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2011-003303-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003303-38.